Cite
HARVARD Citation
Irving, P. et al. (n.d.). OP02 Ustekinumab versus adalimumab for induction and maintenance therapy in Moderate-to-Severe Crohn's Disease: The SEAVUE study. Journal of Crohn's and colitis. pp. S001-S002. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Irving, P. et al. (n.d.). OP02 Ustekinumab versus adalimumab for induction and maintenance therapy in Moderate-to-Severe Crohn's Disease: The SEAVUE study. Journal of Crohn's and colitis. pp. S001-S002. [Online].